Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04329364

RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty

A Randomised Controlled Trial Comparing Conventional Open Haemorrhoidectomy and Laser Haemorrhoidoplasty in the Treatment of Symptomatic Haemorrhoids: COHLAH Trial

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
128 (estimated)
Sponsor
Sengkang General Hospital · Academic / Other
Sex
All
Age
21 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Haemorrhoids or piles are the most common colorectal condition in the local population. Patients often present with bleeding with bowel movement or anal discomfort, both of which causes significant anxiety and stress. For symptomatic sizeable piles, the treatment of choice still remains the conventional open excision (COH). However, this technique carries with it a significant risk of bleeding and pain immediately after the operation, leading to some period of discomfort for the patients. The laser haemorrhoidoplasty procedure (LAH) has been shown in preliminary studies to have less pain, and less complications compared to COH. This study aims to directly compare these two techniques in a local Asian population. The investigators would be conducting a single-centre RCT simultaneously comparing the conventional open Milligan-Morgan haemorrhoidectomy (COH) and the laser haemorrhoidoplasty procedure (LAH) for the treatment of symptomatic grade ll-lV haemorrhoids. Primary outcomes will be post-operative pain while secondary outcomes include post-operative bleeding, readmission and/or reoperations, haemorrhoid-related quality of life (QoL) results and recurrence of symptoms up to a year post procedure

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTLaser Haemorrhoidoplasty (LAH)Using a laser diode to cause coagulative necrosis to the haemorrhoidal cushion
PROCEDUREOpen milligan-morgan conventional haemorrhoidectomyconventional excisional haemorrhoidectomy

Timeline

Start date
2020-10-01
Primary completion
2024-12-31
Completion
2025-06-30
First posted
2020-04-01
Last updated
2024-04-22

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT04329364. Inclusion in this directory is not an endorsement.